Shuttle Pharmaceuticals Holdings, Inc. SHPH
4.01
0.01
0.25%
as of 25 Sep
- Market cap
- $15.6M
- P/E
- 34.7×
Follow SHPH
Insider Buys
alert about insiders buying in the last 12 month
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| (326.36%) | (791.04%) | (27,170.81%) | (551.05%) |
+8 more TTM periods Free account |
|
| (126.42%) | (180.58%) | (507.78%) | (291.97%) | ||
ROIC |
(309.75%) | (387.83%) | 0.00% | 0.00% | |
Return on Tangible Assets |
185.73% | 157.41% | (811.44%) | (345.10%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(18.76) | (58.07) | (50.13) | (93.88) | |
Free Cash Flow |
(9.44) | (9.51) | (11.20) | (10.57) | |
Capital Expenditures |
(0.07) | (0.03) | — | — | |
| Other line items | |||||
Cash ROIC |
(211.27%) | (366.31%) | (320.99%) | (125.50%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.87 | 0.81 | 1.05 | 0.87 | |
Depreciation/Fixed assets |
60.74 | 20.35 | 2.78 | 14.51 | |
Capex/Depreciation |
(0.07) | (0.09) | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(18.62) | (57.89) | (50.13) | (93.88) | |
Capex per Share |
(0.13) | (0.19) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates